dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada GLP-1-RA inhibitors in the management of type 2 diabetes dpp-4_inhibitors [TUSOM | Pharmwiki]

Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: A randomized controlled trial

[Crossref] [PubMed] Ko MW, Chang SC, Ridha MA, et al

British journal of clinical pharmacology , 84 (10), 2325-2335

She explains that liraglutide is less potent, on average, for weight loss than semaglutide or tirzepatide

Probiotics and Type 1 Diabetes: An Interesting Connection A clinical trial on people with type 1 diabetes showed promising results using a probiotic blend ( Bifidobacterium longum , Lactobacillus bulgaricus , Streptococcus thermophilus ) over 12 weeks: Improved fasting blood sugar Reduced post-meal glucose spikes Better overnight stability And this was all without changing their insulin dose, suggesting that the gut flora itself helped balance blood sugar